Vertex Pharmaceuticals Inc / Ma

Tredje AP-fonden VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/12/2026

Shares

73,799

Value ($000)

32,954

Weight

0.2%

2019 Q4 - 2026 Q1 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/12/2026	32,954	0.2%	73,799	3/31/2026
2025 Q4	2/6/2026	59,720	0.4%	131,727	12/31/2025
2025 Q2	8/5/2025	111,568	0.9%	250,602	6/30/2025
2025 Q1	5/8/2025	20,115	0.2%	41,490	3/31/2025
2024 Q4	2/10/2025	55,352	0.5%	137,452	12/31/2024
2024 Q3	11/8/2024	60,216	0.5%	129,474	9/30/2024
2024 Q2	8/12/2024	42,935	0.4%	91,601	6/30/2024
2024 Q1	5/13/2024	43,563	0.5%	104,215	3/31/2024
2023 Q4	2/12/2024	27,349	0.3%	67,215	12/31/2023
2023 Q3	11/9/2023	22,535	0.3%	64,805	9/30/2023
2023 Q2	8/11/2023	22,709	0.3%	64,531	6/30/2023
2023 Q1	5/10/2023	20,118	0.3%	63,853	3/31/2023
2022 Q4	2/10/2023	17,924	0.3%	62,067	12/31/2022
2022 Q3	11/10/2022	16,692	0.3%	57,649	9/30/2022
2022 Q2	8/11/2022	8,078	0.2%	28,666	6/30/2022
2022 Q1	5/9/2022	7,481	0.2%	28,666	3/31/2022
2021 Q4	2/10/2022	6,295	0.1%	28,666	12/31/2021
2021 Q3	11/10/2021	5,200	0.1%	28,666	9/30/2021
2021 Q2	8/6/2021	5,780	0.1%	28,666	6/30/2021
2021 Q1	5/10/2021	6,160	0.1%	28,666	3/31/2021
2020 Q4	2/12/2021	6,775	0.2%	28,666	12/31/2020
2020 Q3	11/10/2020	7,801	0.3%	28,666	9/30/2020
2020 Q2	8/11/2020	8,322	0.3%	28,666	6/30/2020
2020 Q1	5/28/2020	14,420	0.7%	60,600	3/31/2020
2019 Q4	2/10/2020	12,505	0.6%	57,115	12/31/2019